|
ESLA Estrella Immunopharma Inc 1844417 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-2,306,339.00 |
| Balance Sheet |
|
Current Assets
|
$1,824,681.00 |
|
Assets
|
$1,824,681.00 |
|
Current Liabilities
|
$9,256,014.00 |
|
Liabilities
|
$9,256,014.00 |
|
Equity
|
$-7,431,333.00 |
|
Shares Out
|
37765589.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-8,478,748.00 |
|
Investing Cash Flow
|
$4,960,647.00 |
| Market Analysis |
Market Cap
|
$28,324,191.75 |
|
Price
|
$0.75 |
|
PB
|
1.92 |
|
EPS
|
-0.05 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:55 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:45 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ESLA documents filed with the SEC.
ESLA Filings
Clear
